Importantly, excessive expression of Apollon is significantly correlated with unfavorable clinical features at diagnosis, pathological grading of tumor, high cellular proliferation, and poor prognosis in acute myeloid leukemia and lung cancer [16-17]. Here, BIRC6 is linked to lung carcinoma.